Title: Moving beyond Fluorouracil for Colorectal
Cancer Abstract: The New England Journal of Medicine - September
28, 2000 - Vol. 343, No. 13 EDITORIAL Moving beyond Fluorouracil for
Colorectal Cancer For more than 40 years, fluorouracil has been the
mainstay of treatment for advanced colorectal cancer, the second
leading cause of cancer-related death in the United States. The drug
is thought to act primarily by inhibiting the enzyme
thymidylate... Source: The New England Journal of Medicine http://webmedlit.silverplatter.com/j/39d2d0ba0/